Funding for this research was provided by:
Medical Research Council (G0100132)
Text and Data Mining valid from 2018-07-13
Received: 23 January 2018
Accepted: 25 June 2018
First Online: 13 July 2018
Ethics approval and consent to participate
: MRC Myeloma IX trial had a multicentre research ethics committee and local ethics committee’s approval and all patients gave written informed consent in accordance to the Declaration of Helsinki (International Standard Randomised Controlled Trial Number 68454111).
: Not applicable.
: University of Birmingham and MTD own shares in Abingdon Health that manufactures immunodiagnostic tests to quantify FLC levels. PC is a medical advisor to The Binding Site that produces the Freelite assay. The remaining authors have no competing financial interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.